Sun Pharmaceutical Industries Ltd.
Share Price Target & Analysis
NSE:SUNPHARMA
VWAP
Open
Close
High
Low
52 Week High
3.25 (0.19%)
SUNPHARMA
(PHARMA)Sideways to Positive
52 Week Low
EPS
PE
PB
Economical
Quality
Diamond
Valuation
#Analysis
NSE: SUNPHARMA Share Price Financial Analysis & Valuation
Sun Pharmaceutical Industries Ltd. (SUNPHARMA) is broadly categorized in PHARMA segment industry which deals in Pharmaceuticals vertical.
It is one of Large Cap company with Market Capitalization of Rs 195128 (in Cr). Total number of free float shares are 0 (in Lacs).
Sun Pharmaceutical Industries Ltd. is listed on NSE with Exchange ID - INE044A01036 and trading code is NSE:SUNPHARMA with short name Sun Pharma.
Sun Pharmaceutical Industries Ltd. is a most liquid value blue chip company and also listed in TOP 20 Valuation Picks of NSE. SUNPHARMA is having low PE (Price to Earning), low PB (Price to Book) and high DY (Dividend Yield).
Sun Pharmaceutical Industries Ltd. is also traded in Future & Options (Derivative segment of NSE).
In the past 1 year, Sun Pharmaceutical Industries Ltd. has declared an equity dividend of Rs 13.5 per share. At the current share price of SUNPHARMA at Rs 1734.70, this results in a dividend yield of 0.78 %.
As per the Fundamental Analysis of NSE:SUNPHARMA, which uses revenues, earnings, future growth, financial ratios, return on equity, profit margins, and other data to determine SUNPHARMA underlying value and future prospects. All of this data is available in SUNPHARMA financial statements.
Quality of the Stock: As per the fundamental analysis of NSE:SUNPHARMA, it is clearly understood that SUNPHARMA is Economical performer in terms of earnings and profit margins with an EPS of 13.13. NSE:SUNPHARMA book value per share as of today is 98.33. The current price to book ratio for SUNPHARMA as of Mar 31, 2025 is 17.64.
Valuation of the Stock: The current valuation of SUNPHARMA stock is like Diamond which means currently the stock is Very Expensive. Now, it's totally depends upon the risk appetite of an investor and risk-reward ratio of SUNPHARMA whether to BUY this stock at current valuation. The delivery percentage of SUNPHARMA is 65.12% is very crucial parameter which shows that 65.12% investors are anticipating that the price of SUNPHARMA share should go up with VWAP at 1725.59.
Now, the main question is whether to BUY or SELL, NSE:SUNPHARMA at current valuation.
As per latest Analysis No. #3535:-
⇑ STRONG BUY SUNPHARMA if All Greens
⇗ BUY SUNPHARMA (at Lower Levels) if any 2 Greens
⇒ NEUTRAL or HOLD SUNPHARMA (With Stop Loss) if only 1 Green
⇘ SELL SUNPHARMA if NO Green Indicator
NSE: SUNPHARMA Share Price Today (Mar 31, 2025)
(Sun Pharmaceutical Industries Ltd. Daily Analysis on the basis of SUNPHARMA Intraday Graph & Trend)
Sun Pharmaceutical Industries Ltd. share price moved Up by 0.19% from its previous close of Rs 1731.45. SUNPHARMA stock last traded price is 1734.70. SUNPHARMA share price trend is Up with a total of 1956780 stocks traded till now. It has touched an intraday high of Rs 1741.35 and an intraday low of Rs 1705.2. The SUNPHARMA trading at 1734.70, Up by Rs. 3.25, or 0.19 percent which suggests that most of the Traders are anticipating that the price of SUNPHARMA share should go Up.
NSE: SUNPHARMA Share Price Tomorrow Prediction
(Sun Pharmaceutical Industries Ltd. Share Price Prediction for Tomorrow & future forecast is based on Current Trend of SUNPHARMA)
Sun Pharmaceutical Industries Ltd. share price moved Up by 0.19%. SUNPHARMA share price short term trend is Up. It suggests that SUNPHARMA Share Price for Tomorrow remains the same with VWAP at 1725.59 will be treated as stop loss for intraday traders. Sun Pharmaceutical Industries Ltd. Long term investors can follow the SUNPHARMA long term trend as mentiond in future forecast table.
NSE Code |
NSE: SUNPHARMA |
SUNPHARMA Share Price Today |
1734.70 |
SUNPHARMA Share Price Target Prediction for 2025 ^ |
1603.2 - 1970.1 |
SUNPHARMA Share Price Target Prediction for 2026*^ |
1970.1 - 2098.8 |
SUNPHARMA Share Price Target Prediction for 2027*^ |
2098.8 - 2245.7 |
SUNPHARMA Share Price Target Prediction for 2028*^ |
2358 |
SUNPHARMA Share Price Target Prediction for 2029*^ |
2425 |
SUNPHARMA Share Price Target Prediction for 2030*^ |
2644 |
SUNPHARMA Current Book Value 2024 |
97.8 |
*Sun Pharmaceutical Industries Ltd. Short Term & Long Term share price target is based on current financial year earings of the company.
^SUNPHARMA share price target prediction for 2025 2026 2027 to 2030 is based on current market scenario, future forecast & growth assumptions, they might change subject to market sentiments.
SUNPHARMA Technical Analysis
Candlestick Pattern: @1639.5MA | Simple | Action S1 | Expo | Action E2 |
---|---|---|---|---|
MA_5 | 1666.15 | SELL | 1662.79 | SELL |
MA_12 | 1700.72 | SELL | 1693.65 | SELL |
MA_20 | 1716.42 | SELL | 1711.31 | SELL |
MA_32 | 1742.71 | SELL | 1735.76 | SELL |
MA_50 | 1774.74 | SELL | 1753.19 | SELL |
MA_100 | 1791 | SELL | 1767.09 | SELL |
MA_200 | 1731.43 | SELL | 1707.55 | SELL |
Trend Oscillators | Value | Action |
---|---|---|
Bollinger Bands | 1644.64 | OverSold |
MACD | -6.89 | SELL |
ADX | 36 | Strong Trend |
DMI (+/-) | 8.52 / 28.42 | Downtrend |
Momentum Oscillators | Value | Action |
---|---|---|
RSI | 32.94 | Neutral |
STOCHASTIC_K (Fast) | 11.08 | Oversold |
STOCHASTIC_D (Slow) | 15.64 | Oversold |
CCI | -148.35 | SELL |
PSAR | 1747.97 | SELL |
TRUE RANGE | 42.85 | SELL |
ATR | 42.01 | SELL |
WILLIAMS R | -91.52 | Oversold |
TRIX | 0 | Neutral |
STOCHASTIC RSI K | 0 | Oversold |
STOCHASTIC RSI D | 0 | Oversold |
MOMENTUM | -147.35 | SELL |
Duration | Value |
---|---|
1 Year | 5.23% |
3 Months | -8.86% |
1 Month | -8.25% |
1 Week | -4.36% |
Action | Overall (%) |
---|---|
BUY | 3% |
NEUTRAL / HOLD | 7% |
SELL | 90% |
Most popular Questions & Answers about SUNPHARMA
Sun Pharmaceutical Industries Ltd. stock last traded price is 1734.70. SUNPHARMA share price moved Up by 0.19% from its previous close of Rs 1731.45.
Sun Pharmaceutical Industries Ltd. share price trend is Up with a total of 1956780 stocks traded till now. It has touched an intraday high of Rs 1979.9535 and an intraday low of Rs 1705.2. The SUNPHARMA trading at 1734.70, Up by Rs. 3.25, or 0.19 percent which suggests that most of the Traders are anticipating that the price of SUNPHARMA share should go Up and the Stop Loss will be around 1725.59.
The market cap of Sun Pharmaceutical Industries Ltd. is ₹195128 (in Cr) as of Mar 30, 2025.
The current price to earning ratio for Sun Pharmaceutical Industries Ltd. as of Mar 30, 2025 is 46.1.
The current price to book ratio for Sun Pharmaceutical Industries Ltd. as of Mar 30, 2025 is 17.64.
The highest price of Sun Pharmaceutical Industries Ltd. stock is ₹1960.35 in the last 52-week.
The lowest price of Sun Pharmaceutical Industries Ltd. stock is ₹1377.2 in the last 52-week.
Sun Pharmaceutical Industries Ltd. share trading at ₹1734.70, Up by Rs. 3.25, or 0.19 percent which suggests that most of the traders are anticipating that the price of SUNPHARMA share should go Up.
In 2023, Stock price target for Sun Pharmaceutical Industries Ltd. (SUNPHARMA) are ₹1603.2 on downside and ₹1970.1 on upside. Sun Pharmaceutical Industries Ltd. share price target is based on current financial year earings of the company.
In 2024, Stock price target for Sun Pharmaceutical Industries Ltd. (SUNPHARMA) are ₹1970.1 on downside and ₹2098.8 on upside. Sun Pharmaceutical Industries Ltd. share price target is based on forecasted future earnings of the company.
In 2025, Stock price target for Sun Pharmaceutical Industries Ltd. (SUNPHARMA) are ₹2098.8 on downside and ₹2245.7 on upside. Sun Pharmaceutical Industries Ltd. share price target is based on Discounted Cash Flow (DCF) method uses the projected future cash flows of the business.
In next five years, Stock price target for Sun Pharmaceutical Industries Ltd. (SUNPHARMA) will be around ₹2425 Sun Pharmaceutical Industries Ltd. share price target is based on market scenario & growth assumptions, they might change subject to market sentiments and forecasted future earnings of SUNPHARMA.
The price of Sun Pharmaceutical Industries Ltd. (SUNPHARMA) shares moved by 0.19%. The short-term trend for SUNPHARMA share price is Up. It implies that the share price of SUNPHARMA will stay the same tomorrow and that intraday traders should treat VWAP at 1725.59 as a stop loss. Investors with a long-term outlook can track SUNPHARMA long-term trajectory, which is indicated in the future forecast table.
Estimated DCF Value of SUNPHARMA stock is 157.4. Compared to the current market price of 1734.70 INR, the SUNPHARMA stock is Overvalued by 90.9%.
As per the fundamental analysis of Sun Pharmaceutical Industries Ltd. (SUNPHARMA), it is of Economical quality in terms of earnings and profit margins with an EPS of 13.13. Sun Pharmaceutical Industries Ltd. book value per share as of today is 98.33. The current price to book ratio for SUNPHARMA as of Mar 31, 2025 is 17.64.
NSE:SUNPHARMA News & Other Useful Information about SUNPHARMA Share Price
Peer Comparison of NSE: SUNPHARMA
The Peers list includes companies operating in the same industry and having comparable market cap.
Sector: Pharmaceuticals
Company | Price | EPS | BV |
---|---|---|---|
SUNPHARMA | 1734.70 | 13.13 | 98.33 |
DIVISLAB | 5775.45 | 78.09 | 513.62 |
MEDICAMEQ | 480.00 | 7.98 | 173.4 |
CIPLA | 1442.20 | 58.33 | 360.74 |
DRREDDY | 1144.20 | 62.12 | 322.46 |
PGHH | 15925.70 | 189.8 | 324.25 |
TORNTPHARM | 3227.95 | 53.89 | 222.38 |
BIOCON | 341.70 | 5.01 | 90.7 |
LUPIN | 2027.95 | 67.15 | 481.38 |
ALKEM | 4881.70 | 194.78 | 984.46 |